Agoracom Blog Home

Posts Tagged ‘tsx’

CardioComm Solutions $EKG.ca – Remote Patient Monitoring, Reimbursement Topped Headlines in 2019 #Mhealth $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 1:39 PM on Wednesday, December 18th, 2019

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Remote Patient Monitoring, Reimbursement Topped Headlines in 2019

Top mHealth trends in 2019 included remote patient monitoring, telehealth reimbursement, substance use disorder care, chronic disease management, and direct-to-consumer mHealth technology.

  • Based on our most clicked stories in 2019, those trends included remote patient monitoring, telehealth reimbursement and coding, behavioral health/substance use disorder care, chronic disease management strategies, and direct-to-consumer mHealth technologies.

By Samantha McGrail

As 2019 comes to an end, healthcare organizations are reflecting on the trends and stories that most influenced their behaviors in the past year. Based on our most clicked stories in 2019, those trends included remote patient monitoring, telehealth reimbursement and coding, behavioral health/substance use disorder care, chronic disease management strategies, and direct-to-consumer mHealth technologies.

In the following article, mHealthIntelligence.com will break down these trends, as well as the strategies and best practices industry leaders developed in response. 

Remote patient monitoring

In 2019, healthcare organizations looked to invest in remote patient monitoring (RPM) solutions to transition to value-based care. Many healthcare leaders expected these solutions to support high-risk chronically ill patients whose conditions are considered unstable and at a risk for hospital admission. 

Specifically, 88 percent of providers who were surveyed by health IT thought leaders earlier this year had invested or were evaluating investments in RPM technologies. 

RPM solutions have been proven to be clinically effective as an early symptom management tool for chronically ill patients, who represented about 45 percent of the US population according to the survey. These solutions allowed risk-bearing organizations to remotely monitor patients with chronic conditions to help control healthcare costs, improve care quality, and increase access to care for patients in underserved areas. 

In addition, these solutions helped manage value-based risk associated with large patient populations with chronic conditions. 

“The ability of the device to simultaneously record multiple variables such as heart rate and accelerometer data allowed us to more accurately determine the patient’s state, whether he/ she is active, sedentary, asleep, or not currently using the device,” the researchers reported.

Because remote patient monitoring is becoming more widespread, more healthcare organizations are implementing RPM into their health systems. Recently, Humana announced a partnership with Philips Health to launch a remote member monitoring pilot for certain Medicare Advantage members with severe congestive heart failure (CHF).

“Our goal is to continue to find ways to help our Medicare Advantage members stay longer and safer in their homes,” Susan Diamond, president of Humana’s Home Business segment, said in a press release.

Telehealth reimbursement and coding

Along with remote patient monitoring, telehealth has been extremely vital for healthcare in 2018 and will continue to play a significant role going into the new year. But healthcare organizations are still waiting on reimbursement and billing policies to catch up to telehealth adoption..

One of the top read stories from 2019 was the American Medical Association’s (AMA) creation of new codes for the use of telehealth and behavior assessment and intervention services. These codes “more accurately reflect current clinical practice that increasingly emphasizes interdisciplinary care coordination and teamwork with physicians in a primary care and specialty setting,” the association stressed. 

The goal for the new codes was to expand pathways for physicians across the US who deal with diverse patients, including those from underserved areas, and those who have any access to care they may need. 

CMS has followed suit, implementing the AMA and its Digital Medicine Payment Advisory Group to include new telehealth codes in the 2018 Medicare physician fee schedule. And in the beginning of this year, CMS released its 2020 physician fee schedule that included numerous additions that will enable more reimbursement for connected health services next year. 

In October of this year, Pennsylvania tried again to pass comprehensive telehealth legislation after the bill was denied last year because of disagreements over payment parity. 

State Senator Elder Vogel introduced The Telemedicine Act (SB 857), which aimed to establish definitions for telemedicine and telehealth, provide temporary evaluation and treatment guidelines for reimbursement, and give state departments up to two years to draft permanent rules and regulations. 

The new bill includes remote patient monitoring technologies, which gives providers the opportunity to use these connected health services. About a dozen states have passed legislation demanding payment parity for telehealth, but most have failed because of strong opposition from healthcare payers. 

Addressing substance abuse using mHealth

An estimated 115 people die each day from opioid abuse, an issue that has become more widespread in the past decade. Healthcare providers have been actively searching for a solution to tackle this issue, and many have found a pathway to success using mHealth and telehealth technology.

Applying MHealth and telehealth technology to addiction treatment is expected to make one of the biggest impacts on substance use disorder care. Connected health platforms allow providers to work with the individual patient anytime they need to, and are able to see what the patient experiences each day. 

“We’re building a panoramic view of your life,” said Jacob Levenson, CEO of MAP Health Management, a Texas-based national network of almost 100 addiction treatment providers. The organization has adopted digital health tools for care management and coordination of substance use disorder patients.

The smartphone is also a great tool for addiction treatment, as it offers both a platform for population health programs and individual treatments. Healthcare providers are able to send out messages offering support or information via text, SMS, or e-mail to large groups at any time. They can also personalize messages for individuals, connecting information to one’s habits, location, or medical record.

MHealth apps are becoming increasingly more popular tools. Apps could feature surveys, messaging or chat rooms, links to resources, messaging with care providers or a substance abuse specialist, and a 911 link for immediate help. 

“Medical devices, including digital health devices like mobile medical apps, have the potential to play a unique and important role in tackling the opioid crisis,” FDA Commissioner Scott Gottlieb, MD, said in a press release featured on the FDA website. “We must advance new ways to find tools to help address the human and financial toll of opioid addiction.” 

Chronic disease management strategies

While MHealth platforms were important for addressing the opioid crisis, the solutions have also been useful for chronic disease management. A growing number of Americans are suffering from more than one chronic condition, prompting more healthcare providers to take the appropriate measures to tackle this issue in 2019.

For example, in January, Omada Health, a digital therapeutics company that focuses on obesity-related chronic conditions, created a cognitive behavioral therapy program (CBT) for those dealing with depression and anxiety. 

“Depression and anxiety are a known barrier to healthy behaviors including medication adherence, optimal nutrition, and seeking timely preventive care. With the addition of CBT curriculum, we can more fully support our participants as they manage their conditions. And, through our digital platform, we can do it at scale,” Carolyn Bradner Jasik, MD, Omada’s Vice President of Medical Affairs, explained in a press release.

The challenge going into the coming years is developing a digital health platform that is able to integrate different programs and allow for easy access for both patients and providers.

A few weeks ago, a Pennsylvania health system also created a telehealth and remote patient monitoring platform to allow patients living with ALS to receive at home care. Most patients with ALS have to travel hours for meetings with doctors and specialists, which can prove to be challenging. But the telehealth platform allows the meetings to be held at home. 

Heart failure (HF) patients receiving targeted virtual behavior therapy found significant improvements in self-care, a recent study published in the journal Circulation found. The study conducted by Humana and AbleTo found a correlation between improving behavioral health care and co-existing physical conditions. The study also noted improvements in self-care, depression symptoms, and awareness of physician recommendations among patients that received HF-focused virtual behavioral therapy over eight weeks.

Chronic disease management is vital to reduce costs by addressing the patient’s illness or condition with maximum clinical outcomes, while helping beneficiaries control their disease in an effective way. 

Direct-to-consumer mHealth technology

The healthcare industry is facing major disruption from non-traditional companies, like Amazon, Google, and Apple. The mHealth space has been no different according to the top stories from 2019.

In September of this year, Amazon prepared to take on the direct-to-consumer telehealth industry through its new platform, Amazon Care. Amazon Care is a virtual care clinic offering telehealth and mHealth services for its employees in the Seattle area, including on-demand access to a clinician online messaging for healthcare questions, a prescription service, and the option of scheduling an appointment through Seattle-based Oasis Medical. 

Apple Watch can be used by clinicians to detect atrial fibrillation. But will care providers rely on these devices to present them with accurate information?

A survey of 420,000 individuals conducted by researchers at the Stanford University School of Medicine found that over an eight month span, the Apple Watch detected an irregular heart rate in .52 percent of individuals or 2,161 people. And almost three-quarters of the users who were notified about an irregular pulse contacted a care provider for further treatment.

“The study’s findings will help patients and clinicians understand how devices like Apple Watch can play a role in identifying atrial fibrillation, a deadly and often undiagnosed disease,” Mintu Turakhia, MD, an associate professor of cardiovascular medicine, said in the press release. “Additionally, these important findings lay the foundation for further research into the use of emerging wearable technologies in clinical practice and demonstrate the unique potential of large-scale app-based studies.”

In addition, a Gallup survey this month showed that nearly one in five Americans are using an mHealth wearable. Adults younger than 55 are twice as likely to use or have used mHealth. And individuals older than 55 and women, are more interested in using mHealth than men. About half of the women respondents under 55 said they use or have used mHealth in the past. While men over age 55 are the least likely to use or have used the technology.

Jefferson Health recently partnered with Quick’r Care to create a mHealth platform to allow patients to choose their correct care path. Through JeffConnect’s virtual care service. Consumers will have on-demand video access to health system’s care providers.

“This is what people who feel bad need right now, right when they begin to feel sick,” added Stephen K. Klasko, MD, president of Thomas Jefferson University and CEO of Jefferson Health. “Working with Quick’rCare allows us to expand our commitment to healthcare with no address.”

Overall, Apple products are designed to make healthcare more human. Devices are meant to protect patient data and give easy accessibility to everyone who uses Apple products. Patients are able to access medical records and communicate from at home if needed. But providers continue to question whether the information they are receiving is accurate, as with new technologies, there isn’t always this guarantee.

Source: https://mhealthintelligence.com/news/remote-patient-monitoring-reimbursement-topped-headlines-in-2019

#Edtech Firm Springboard Raises $11 Mn From Reach Capital, Others To Expand Operations – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 11:07 AM on Wednesday, December 18th, 2019
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

Edtech Firm Springboard Raises $11 Mn From Reach Capital, Others To Expand Operations

  • Pearson Ventures, IFC, Costanoa Ventures, Learn Capital, and Blue Fog Capital also participated in funding round
  • Springboard will invest funds in expanding operations, adding more courses, hire more employees
  • Springboard has also partnered with US-based tech giant Microsoft

Aman Rawat

San Francisco and Bengaluru-based online edtech startup Springboard has raised $11 Mn in a post-Series-A funding round led by Reach Capital. Venture capital companies such as Pearson Ventures, International Finance Corporation (IFC), as well as its existing investors Costanoa Ventures, Learn Capital, and Blue Fog Capital also participated in the funding round.

With the recently raised funds, Springboard will expand its operations, add more courses, and bring more talent to the company. “We will use this funding to grow our Indian presence with more courses in design and software engineering and continue our expansion into additional geographies,” said Vivek Kumar, Springboard India’s managing director.

Though the current employee strength of the company stands at 130, Springboard plans to increase the headcount to over 200 in the next few quarters.

Springboard has also partnered with US-based tech giant Microsoft to train and provide jobs to 5,000 students in the analytics profession over the next three years through its new Data Analytics Career Track platform, which is co-developed by the tech company.

Further, in this partnership, Microsoft will provide educational content and access to its tools. On the other hand, Springboard will provide mentorship, support and career services.

Founded in 2013 by Gautam Tambay and Parul Gupta, Springboard is a workforce upskilling edtech startup that offers online courses and extensive mentor-based learning for early and mid-level professionals in data science, UX design, digital marketing, and other technology areas. The company has so far raised $20 Mn in funding.

Highlighting the need for upskilling of developers which comes in every three to five years, Kumar said that the company’s industry-designed programmes, combined with in-depth, one-on-one mentorship and career guidance, enable people to achieve their full potential.

The company claims to have enrolled over 14K students for its programmes worldwide. Notably, in 2019, the company has launched three new programmes for tech learners in India. “Springboard plans to grow its Indian presence with more courses in design and software engineering,” Kumar was quoted as saying.

Kumar further claimed that for its skilling courses, the company has so far maintained a 99.9% success rate in job guarantee programmes.

According to a report by Google and KPMG, the edtech market is expected to have a significant impact on the online education sector, which has the potential to touch $1.96 Bn by 2021 from $247 Mn at present.

The Indian education market is vast, complex, and has innumerable existing gaps. So, despite the proliferation of both Indian and foreign edtech companies, there is still enough scope to leverage the upskilling game.

In India, Springboard competes with startups such as Udacity, Coursera, Udemy, and Progate which are also leveraging their online platforms in helping tech employees upskill their skills and remain relevant to the changing times.

Source: https://inc42.com/buzz/springboard-raises-11-mn-from-reach-capital-others-to-expand-operations/

PRIMO Nutraceuticals Inc. $PRMO.ca – Lawmakers pressure #FDA to make clear guidelines on #CBD $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 10:12 AM on Wednesday, December 18th, 2019

SPONSOR:  PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

Lawmakers pressure FDA to make clear guidelines on CBD

  • With the passing of the 2018 Farm Bill, farmers, manufacturers and consumers are keeping a watchful eye on the agency and how they might address compliance for the thousands of companies selling the product and the millions of consumers vying to use it. 

June 25, 2019, Senator Ron Wyden sent a letter to the Department of Health and Human Services and the Food and Drug  Administration urging both entities to provide clarity around CBD products derived from hemp.

The FDA has been under a magnifying glass since hemp was declassified as a schedule I drug, having formerly fallen under the thumb of the Controlled Substances Act of 1970.

With the passing of the 2018 Farm Bill, farmers, manufacturers and consumers are keeping a watchful eye on the agency and how they might address compliance for the thousands of companies selling the product and the millions of consumers vying to use it. 

Yet silence and lack of clarification on a potential path towards compliance for supplement producers has left many chomping at the bit for the agency to come up with regulatory guidelines for selling Food and dietary supplements containing CBD. In the interim, well-established companies such as Next Green Wave, Inc. (Next Green Wave, NGW:CSE | NXGWF:OTCQX) have continued to solidify their position in the market, ready and able to serve the exponentially growing demand of what promises to be a $20 plus billion-dollar industry.

A Slow and Arduous Process

In Wyden’s letter, the lawmaker criticized the FDA’s indication that it could take up to 3 to 5 years for the FDA to implement final regulations for companies to lawfully sell CBD infused foods, calling the suggestion “unacceptable.” Wyden wrote that he urges the FDA to quickly implement “enforcement discretion guidelines” by August 1, then issue an interim final rule pending a permanent rule so that companies will have clarity on how CBD  in food and dietary products will be regulated. 

This argument may have fallen on attentive ears, but as of the date of this publication, the FDA has yet to provide any clear established guidelines. Although the agency has wielded their powers against a handful of “bad actors”, their approach seems to be that of “wait and see” with regards to due process.

The letter penned by Wyden also stressed the economic impact growers in states like Oregon would benefit from by allowing CBD to be in more products, but are halted until the FDA gives the okay that CBD in ingestible products is lawful to sell and okay to use. 

However, this isn’t the first letter Wyden has sent to the agency regarding a regulatory pathway to CBD commercialization. In January the lawmaker co-authored a letter with Senator Jeff Merkley telling the FDA they must revamp current legislation around offering CBD products. Both senators advised former commissioner Scott Gottlieb to “immediately begin updating regulations for hemp-derived CBD and other hemp-derived cannabinoids, and give U.S. producers more flexibility in the production, consumption, and sale of hemp products,” according to the letter. 

FDA is listening to public demand for clear CBD regulations

The FDA has slowly but surely has been taking measures to develop guidelines around selling CBD ingestible-products. In late May, the agency held a public hearing allowing stakeholders the opportunity to share their reasons why the FDA-regulation for CBD food and dietary products is crucial, according to the Chicago Tribune

The agency also gave a chance for the public to weigh in on CBD regulation by opening a public docket for individuals to add comments. The deadline to submit comments was July 16, and the agency received over 3,000 comments, according to the Chicago Tribune. In conjunction with the open docket, the FDA also published an article July 17 echoing the agency’s stance on CBD and concern for public safety.

“We recognize that there is significant public interest in these products, for therapeutic purposes and otherwise,” the article said. “At the same time, there are many unanswered questions about the science, safety, and quality of many of these products. As we approach these questions, we do so as a science-based regulatory agency committed to our mission of protecting and promoting public health.” 

In the “Listening to and learning from stakeholders” section of the article, the FDA insists that relative questions must be answered in order to develop a clear pathway to regulate CBD products which include the following: 

  • How much CBD is safe to consume in a day? How does it vary depending on what form it’s taken?
  • Are there drug interactions that need to be monitored?
  • What are the impacts on special populations, like children, the elderly, and pregnant or lactating women?
  • What are the risks of long-term exposure?

In a second article published on the same day, the FDA stressed it has not approved any CBD products besides Epidiolex, a drug which treats seizures caused by epilepsy. And is currently working to figure out how CBD will affect body parts, special populations and pets. 

Since both the public hearing and window to submit comments to the FDA have both passed, the agency says it will review submitted information and intends to follow up with its findings “around the end of summer/early fall,” according to the Chicago Tribune. 

It is unclear if the FDA will tentatively meet this deadline, but the agency will most likely continue to be pressured by lawmakers and the public to provide a regulatory framework around the selling and obtaining CBD food and dietary supplements. 

Source: https://t2conline.com/lawmakers-pressure-fda-to-make-clear-guidelines-on-cbd/

Can Better Internet Connectivity in India Give Education a Push? – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca #Edtech

Posted by AGORACOM-JC at 5:57 PM on Tuesday, December 17th, 2019
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

Can Better Internet Connectivity in India Give Education a Push?

  • Leveraging internet connectivity, edtech apps are personalising practice sessions for millions of children
  • Using advanced technology like artificial intelligence and machine learning, edtech apps study individual student behaviour

By: Zisshan Hayath

Let’s go back to the time when Facebook first made its entrance in India. Most people didn’t have computers at home – and they would end up travelling a few kilometres just to reach a cyber cafe and access social networks. Instant messages and emails received slower replies and even owning a mobile phone was a luxury for the youth. Cheap mobile data was unheard of.

In just a little over a decade, the scene in India is completely different. Every other person, especially in urban areas, has access to mobile phones and laptops. India has one of the cheapest mobile data plans in the world. This has revolutionised the way mobile phones are used, even perceived.

Today, mobile devices have gone beyond their primary role of interpersonal connectivity. Today, mobile devices are a mode of convenience, entertainment, consumerism and education.

Initially, the term e-learning was only used in the context of large scale MNCs helping their employees learn on the go by eliminating classrooms. In the span of a few years, of the 300 million school going students, several million have registered themselves on e-learning apps.

So how is internet connectivity helping Indian students learn better for better results?

Accessibility:

In a traditional learning setup, quality teachers, books, and infrastructure are only concentrated in metros and education hubs. With the internet becoming easily affordable, eLearning apps leverage this connectivity to ensure that every child in in the country has access to high-quality teachers. Using live classes, children can watch India’s best teachers explain complex concepts, ask questions, and get them answered in real-time.

Personalisation:

The teacher-student ratio in Indian classrooms is extremely skewed, with one teacher for about 30-35 students on average. This number gets worse in tier II and III cities. Due to this, teachers cannot give students any personal attention. They use a one-size-fits-all approach for every child, without considering their aptitude, grasping power, strengths, and weaknesses. Due to India’s vast population and weak infrastructure, it is a mammoth task to improve this.

However, this can be easily resolved using edtech. Leveraging internet connectivity, edtech apps are personalising practice sessions for millions of children. Using advanced technology like artificial intelligence and machine learning, edtech apps study individual student behaviour.

Using this data, they start every student’s practice at a level that they’re comfortable with. The difficulty of questions is then increased until the student meets their individual learning goals.

24×7 Instant Doubt Resolution:

One of the key hindrances in every student’s learning journey is doubts. In a classroom set up, students end up waiting for weeks, if not months until the teacher completes the syllabus and then organises doubt-solving sessions. The end result is that the student’s learning journey is affected and so is their understanding of not just the topic in question, but other topics as well. They end up rote learning these topics, but this does not help when they appear for national level board or competitive exams.

Using internet connectivity, learning apps have created a chat platform where students can ask their questions. They are instantly connected to an expert who resolves their doubt for them in under a minute.

In fact, this platform, often called Live Doubts or Doubts on Chat has become so popular, that edtech apps are using natural language processing to create a bot that can answer student doubts instantly, based on the millions of questions asked earlier. If the bot cannot find an answer, or if the student has any further questions, the student can choose to chat with a live expert. As of now, over 25 percent of all doubts are solved using this bot.

Internet is bringing a revolution in every industry across India. From booking a cab to movie tickets, groceries, and games – every industry has undergone a major shift for the better. It’s now time for parents to embrace edtech and help their children learn better.

(Zishaan Hayath is the Founder and CEO of Toppr, a learning app that provides personalised learning for students studying for boards, Olympiads, and various engineering and medical competitive exams.) Chennai: In little over 3 months since video platform Tiktok ..

Read more at:
http://timesofindia.indiatimes.com/articleshow/72553189.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

Deficit-hit #palladium takes aim at $2,000 ceiling in record run – SPONSOR: New Age Metals $NAM.ca $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 2:53 PM on Tuesday, December 17th, 2019

SPONSOR: New Age Metals Inc. The company owns one of North America’s largest primary platinum group metals deposit in Sudbury, Canada. Updated NI 43-101 Mineral Resource Estimate 2,867,000 PdEq Measured and Indicated Ounces, with an additional 1,059,000 PdEq Ounces Inferred. Learn More.

Deficit-hit palladium takes aim at $2,000 ceiling in record run

  • “Supply is tight in the palladium market and when you’re adding the speculation about a potential pick-up in demand due to recovery in the global economy, you have a perfect storm of bullish news continuing to keep it supported,” Saxo Bank analyst Ole Hansen said.

(Reuters) – Scarce palladium soared on Tuesday, nearing a breach of the $2,000 an ounce level for the first time, with a “phase one” U.S.-China trade deal driving prospects of a pick-up in demand and helping the autocatalyst metal extend a record run.

Palladium was up 0.6% at $1,989.58 an ounce at 1035 GMT, after hitting an all-time high of $1,998.43.

“Supply is tight in the palladium market and when you’re adding the speculation about a potential pick-up in demand due to recovery in the global economy, you have a perfect storm of bullish news continuing to keep it supported,” Saxo Bank analyst Ole Hansen said.

However, he added: “Liquidity is poor, which means that if we see a correction, it can be quite brutal and could take palladium back down towards $1,850, although there are no signs of that right now.”

The phase one trade deal has been “absolutely completed”, a top White House adviser said on Monday. However, Chinese officials have been more cautious, emphasizing the dispute has not been completely settled.

Palladium, used mainly in vehicle catalytic converters, has gained more than 57% so far this year because of a sustained supply crunch.

“We look set for an imminent test above $2,000,” MKS PAMP said in a note.

Elsewhere, gold prices rose due to uncertainty driven by a lack of concrete details about the interim trade deal.

Spot gold rose 0.2% to $1,478.41 per ounce. U.S. gold futures were also up 0.2%, at $1,482.90.

The trade dispute will be an influencing factor for gold throughout next year, said Commerzbank analyst Daniel Briesemann, adding a phase two deal would be much more difficult since a lot of critical issues had been left out of the current agreement.

“We must be prepared for some volatility and uncertainty. It’s not yet a done deal.”

Gold, considered a safe investment during political and economic uncertainty, has gained about 15% this year, mainly driven by the 17-month-long tariff war and its impact on the global economy.

Also helping bullion, European stocks slid from record highs on reports that Britain’s prime minister was ready to play rough in Brexit talks, souring sentiment somewhat after a record rally during the Asian session on the trade optimism.

Silver was 0.2% higher at $17.07 per ounce, while platinum gained 0.3% to $932.32.

Source: https://www.onenewspage.us/n/Business/1zkl56ztmy/Deficit-hit-palladium-takes-aim-at-000.htm

CardioComm Solutions $EKG.ca – #Mhealth Technologies Market Projected to Gain Significant Value $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 11:59 AM on Tuesday, December 17th, 2019

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Mobile Health (MHealth) Technologies Market Projected to Gain Significant Value

By: trendsmarketresearch

  • The global mHealth market should reach $46.2 billion by 2021 from $13.2 billion in 2016 at a compound annual growth rate (CAGR) of 28.6%, from 2016 to 2021.

Report Scope:

This new report on mobile health will provide a brief description of the current status of the industry and recent developments. It presents the changing environment, in terms of new challenges and opportunities for app development, remote monitoring and networking medical data. The report analyzes the market trends, leading service providers, therapeutic markets and the most popular mHealth applications, in terms of downloads and revenues.

Report Includes:

– A global overview of the mobile health technology market.
– Analyses of global market trends, with data from 2014 and 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
– A presentation of the changing mobile health technology environment in terms of new challenges and rising opportunities.
– Information regarding market trends, leading service providers, therapy markets, and the most popular mHealth applications.
– Insight into the second generation of mHealth devices, projected regulatory patterns, and innovative devices and services to be launched in the near future.
– Company profiles of major players in the industries covered.

Report Summary

Mobile health (mHealth) is the use of mobile and wireless technologies to support healthcare systems and achieve healthcare objectives. Digital health solutions have the potential to improve the quality of healthcare, to democratize medical knowledge and provide healthcare to billions or people who have limited or no access to services. The provision of healthcare remains high on the economic and political agenda and continues to demand a huge share of gross domestic product (GDP) in industrialized countries, where an aging population and increase in the prevalence of chronic noncommunicable diseases (NCDs) remains a challenge.

mHealth can provide better and more consistence solutions within the global healthcare environment and will change the way services are provided in the future. Smart devices and wearable are empowering individuals to more effectively manage their care, raising awareness, providing continuous monitoring and disseminating of information to the patient and healthcare professionals; driving a more proactive, patient-centric healthcare system.

Source: https://statsflash.com/mobile-health-mhealth-technologies-market-projected-to-gain-significant-value-by-to-2021/743242/

PRIMO Nutraceuticals Inc. $PRMO.ca – Here’s Why Dollar General $DG Has High Hopes for #CBD $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 10:27 AM on Tuesday, December 17th, 2019

SPONSOR:  PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

Here’s Why Dollar General Has High Hopes for CBD

By: Rich Duprey

  • Dollar General (NYSE: DG) is jumping on the CBD bandwagon, announcing it intends to start selling products infused with cannabidiol in 1,100 stores across seven states by spring 2020
  • Limiting its selection of goods to topical products such as creams, ointments, bath bombs, bath salts, and face masks. Edibles are not part of the plan.

Yet where grocery stores, shoe stores, pharmacies, and wellness stores have all previously said they, too, were joining the conga line of retailers selling CBD products, the dollar store chain’s entry has a greater chance of boosting its bottom line.

Image source: Getty Images.

Business is growing like a weed

Unlike many other retailers and even rival Dollar Tree, Dollar General is on fire, giving a master class in discount retailing in the third quarter. Sales rose 9% to $7 billion on a near-5% increase in comparable-store sales, generating a 13% rise in earnings per share. Management also raised top- and bottom line guidance for the year.

It was tough to pick out a category that was best, as it saw across-the-board sales increases, but it was enough for the discount chain to know it needed to pick up the pace of expansion. Where it expects to open 975 new stores this year, it plans on opening another 1,000 in 2020. In all, Dollar General will be involved in 20% more real estate projects next year than it was this year. 

That’s important because as it continues to reach further into all regions of the country, getting closer to its target customer, CBD products afford it the opportunity to accelerate that growth.

The madness of cannabis

Marijuana, cannabis, and cannabidiol all live in a legal purgatory. Although a number of states have legalized marijuana for personal use, it officially remains a controlled dangerous substance at the federal level.

Cannabis, on the other hand, essentially comprises two categories, marijuana and hemp, with the major difference being the presence of tetrahydrocannabinol, or THC, the psychoactive compound that gets a user high. While hemp does contain THC, it is at very low levels and not enough to get someone high. The 2018 Farm Bill removed hemp and hemp-derived products from its list of controlled dangerous substances.

CBD is one of over 100 compounds found in cannabis, but unlike THC, it doesn’t get you high. Also, where marijuana has very little CBD, hemp has a lot. Many also believe CBD has a variety of therapeutic properties, and though some studies have seemingly backed up the claim, there haven’t been very many studies, and the long-term implications from its use are still unknown. 

A green business 

The Food and Drug Administration is slow-walking the formulation of a coherent policy on CBD, which has put many retailers in limbo on just how best to proceed. What the FDA was clear about in its recent policy update, however, was that it is illegal to add CBD to food or supplements. That’s why you see retailers opting for topical applications of the compound. 

Cannabidiol has another benefit for the retail industry in that it enjoys over dried cannabis, or so-called legal weed. Consumers have demonstrated willingness to pay up for the compound, and there is a plentiful supply of CBD, suggesting profits will remain stable. 

That’s an attractive feature for low-margin businesses like grocery stores. But Dollar General, which sells merchandise at many different price points, tends to make up in volume what it loses out in product markups. Driving down the cost of CBD-infused products could cause consumers to flock to its stores. 

And for a discount chain, Dollar General is a relatively high-profit-margin business. Over the past five years, its operating margins stand at almost 9% and net margins are 6%. But compare that with other retailers that have announced they will be selling CBD products.

Retailer5-Year Operating Margin5-Year Net Margin
Dollar General8.9%6%
Dollar Tree8.4%2.5%
CVS Health 5.6%2.6%
Rite Aid 1.6%2.1%
Walgreens 4.6%3.5%
Kroger 2.6%1.9%

Data source: Morningstar. 

A smoking hot opportunity

The retail market is expected to be the biggest contributor to CBD’s growth, accounting for 60% of the forecast $20 billion in annual sales. Dollar General has the potential to bring CBD products to more people and attract a bigger share of the market because of its value proposition.

While there may be questions about the viability and efficacy of the CBD in the products it offers (a question that looms over all retailers selling CBD products), CBD has a higher chance of moving the needle for Dollar General than it does for anyone else. Source: https://www.nasdaq.com/articles/heres-why-dollar-general-has-high-hopes-for-cbd-2019-12-17

NORTHBUD $NBUD.ca – Ontario sold the most #cannabis in first year of legalization $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 5:20 PM on Monday, December 16th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

Ontario sold the most cannabis in first year of legalization

  • Ontario accounted for $217 million in recreational cannabis sales — or 24 per cent of the overall Canadian market
  • From October 2018 to September 2019, followed by Alberta and Quebec, which sold $196 million and $195 million worth, respectively

By: Vanmala Subramaniam

Cannabis retailers in Ontario sold the most cannabis of any province in the first year following legalization, even though there was only one online store and 24 brick-and-mortar stores in operation for most of that period, according to new Statistics Canada data.

Ontario accounted for $217 million in recreational cannabis sales — or 24 per cent of the overall Canadian market — from October 2018 to September 2019, followed by Alberta and Quebec, which sold $196 million and $195 million worth, respectively.

The year following legalization saw more than 400 brick-and-mortar stores established across the country. Total adult-use cannabis sales from online retail stores amounted to $908 million for that period, far short of many estimates prior to legalization.

For instance, a June 2018 report from CIBC estimated that legal cannabis sales could reach $6.5 billion by 2020, with the potential to yield $1 billion in EBITDA. A similar report by Deloitte had forecast the legal cannabis market to generate $4.3 billion in sales in the year following legalization.

The StatsCanada data also observed a sharp decline in the number of consumers who purchased cannabis online, in tandem with the growth of the number of retail stores across the country. The share of online sales declined from 43.4 per cent in Oct. 2018 to just 5.9 per cent the following September, while the number of brick-and-mortar stores rose 88 per cent between March and July 2019.

Online retail stores — most of which are operated by provincial wholesalers — made approximately $120 million in the year following legalization, while brick-and-mortar stores raked in the remaining $788 million in sales.

Indeed, government-run stores have been struggling. Ontario Cannabis Retail Corp. which operates the Ontario Cannabis Store, lost $42 million in its latest fiscal year ending March 31, 2019. In New Brunswick, Cannabis NB, the crown corporation in charge of selling cannabis, recently said it was looking for a buyer, as losses piled up.

On a per capita basis, British Columbia reported the lowest sales values in the country at $10 per capita in the year following legalization. Ontario did not fare much better on that measure, with a per capita sales value of $15. Alberta, by contrast, had one of the highest per capita sales values at $45.

Statistics Canada attributed these vast differences to varying access to cannabis stores. In Ontario, for instance, just nine per cent of residents lived within a three kilometre distance to a cannabis store, whereas in Alberta — the province with the highest number of stores — 50 per cent of residents lived within three kilometres of a cannabis store.

The Canadian cannabis industry has, for the most part, struggled to meet expectations from both investors and consumers, with price, quality and accessibility being the key reasons why the sector did not take off at a rate many had hoped it would.

While the first few months of legalization were characterized by a supply shortage, the production ramp-up in the latter half of 2019 has now created the opposite problem: oversupply.

Cannabis producers are urging the Ontario government to open up the licensing process for retail stores, which they hope will lead to a sharp growth in the number of stores across Canada’s most populous province.

Source: https://business.financialpost.com/cannabis/cannabis-business/ontario-sold-the-most-cannabis-in-first-year-of-legalization-despite-low-store-count

#Palladium prices rally to record high – SPONSOR: New Age Metals $NAM.ca $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 4:24 PM on Monday, December 16th, 2019

SPONSOR: New Age Metals Inc. The company owns one of North America’s largest primary platinum group metals deposit in Sudbury, Canada. Updated NI 43-101 Mineral Resource Estimate 2,867,000 PdEq Measured and Indicated Ounces, with an additional 1,059,000 PdEq Ounces Inferred. Learn More.

Palladium prices rally to record high

  • “Palladium has been on a multi-year run that shows few signs of abating,” John Ciampaglia, chief executive officer of Sprott Asset Management

by Denton Staff Contributor

Palladium futures rallied Friday to their highest settlement on record, extending last year’s advance and narrowing their price spread with gold to the smallest in roughly 16 years.

“Palladium has been on a multi-year run that shows few signs of abating,” John Ciampaglia, chief executive officer of Sprott Asset Management, wrote in a recent report. “Palladium is close to becoming the most ‘precious’ of precious metals.”

Palladium, which is used in pollution-controlling catalytic converters on gasoline-powered vehicles, has been significantly narrowing its spread with gold prices.

‘Palladium is close to becoming the most “precious” of precious metals.’ John Ciampaglia, Sprott Asset Management

On Friday, March palladium  added $34.10, or 2.8%, to settle at $1,234.40 an ounce. The finish was the highest based on FactSet records dating back to November 1984, topping the previous record settlement of $1,201.30 from Dec. 19.

February gold  fell $9, or 7%, to finish at $1,285.80 an ounce dulled investment demand in the yellow metal. That helped narrow its spread with palladium futures down to $51.40, the lowest since November 2002, according to Dow Jones Market Data. The last time palladium settled higher than gold was in October 2002.

Overall, growing global demand for the industrial metal has fed worries about tighter supplies.

“While the escalating U.S.-China trade war hurt many commodities in 2018, it couldn’t dent palladium’s rise,” said Ciampaglia. “Demand for palladium was especially strong last year, as environmental concerns have prompted a global shift from diesel to gasoline and hybrid vehicles.”

“Not even the 2018 slowdown in China’s auto market, the world’s largest, dampened demand,” he said.

Auto sales in China, the biggest global market, were on track for their annual decline in three decades after plunging 16% in November.

News Friday on progress toward a U.S.-China trade deal was upbeat, however. China’s Commerce Ministry confirmed that a delegation of U.S. officials will travel to Beijing for a new round of trade talks on Monday and Tuesday, .

“Supply shortages continue to support palladium’s performance, with strong multi-year growth in palladium demand now straining a fixed supply,” Ciampaglia said. “Palladium is especially scarce and its supply is inelastic since it is usually a by-product of ores that are being mined for other metals, like platinum and rhodium.”

Source: https://dentondaily.com/palladium-prices-rally-to-record-high-now-nearing-golds-level/

CardioComm Solutions $EKG.ca – #Mhealth Market Latest Innovations and Industry Analysis $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 2:29 PM on Monday, December 16th, 2019

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Digital Health Market Latest Innovations and Industry Analysis

  • Rapid Adoption of mHealth Technologies Drives the Market
  • “Rising number of government initiatives aimed at promoting digital health solutions will enable growth in the market,”

The Global Digital Health Market is driven by several factors. “Rising number of government initiatives aimed at promoting digital health solutions will enable growth in the market,” said a lead analyst at Fortune Business insights. “In the coming years the digital health market is estimated to benefit from the uptake of IT in the medical industry,” he added. With the increasing use of smartphones across the world the demand for digital health services is growing owing to the rising adoption of mhealth apps.

Other factors such as the rising demand for in-house remote monitoring devices and increasing geriatric population will catalyze growth of the digital health and wellness services. Digital health over the past few years has become a game changer in the digital health industry. Digital health services help in monitoring diseases and provide access to electronic information of patients through tablets or mobiles. Doctors can check the complete digital health record of their patients and accordingly offer the best consultation. All the factors mentioned above are anticipated to boost the digital health market during the forecast period.

Read More: http://rentfint.com/2019/12/16/digital-health-market-latest-innovations-industry-analysis-segmentation-research-report-opportunities-forecast-till-2026/